ConductScience.org, home

Trial · NCT01166139

Adverse events40

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherProlonged QTCCardiac disordersNilotinib 400 mg Twice Daily679
otherIncreased ASTInvestigationsNilotinib 400 mg Twice Daily576
otherElevated Total BilirubinInvestigationsNilotinib 400 mg Twice Daily576
otherIncreased ALTInvestigationsNilotinib 400 mg Twice Daily475
otherAnemiaBlood and lymphatic system disordersNilotinib 400 mg Twice Daily373
otherHyperglycemiaMetabolism and nutrition disordersNilotinib 400 mg Twice Daily373
otherHeadacheNervous system disordersNilotinib 400 mg Twice Daily373
otherNauseaEar and labyrinth disordersNilotinib 400 mg Twice Daily272
otherRefluxGastrointestinal disordersNilotinib 400 mg Twice Daily272
otherElevated ESRBlood and lymphatic system disordersNilotinib 400 mg Twice Daily272
otherIncreased LipaseInvestigationsNilotinib 400 mg Twice Daily272
otherIncreased AmylaseInvestigationsNilotinib 400 mg Twice Daily272
otherUpper Respiratory InfectionRespiratory, thoracic and mediastinal disordersNilotinib 400 mg Twice Daily272
otherVomitingMetabolism and nutrition disordersNilotinib 400 mg Twice Daily172
otherDecreased White Blood Cell CountBlood and lymphatic system disordersNilotinib 400 mg Twice Daily171
otherIncreased White Blood Cell CountBlood and lymphatic system disordersNilotinib 400 mg Twice Daily171
otherCoronary Artery DiseaseCardiac disordersNilotinib 400 mg Twice Daily171
otherSyncopeNervous system disordersNilotinib 400 mg Twice Daily171
otherHospitalization for CABGCardiac disordersNilotinib 400 mg Twice Daily171
otherAllergic RhinitisInfections and infestationsNilotinib 400 mg Twice Daily171

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01166139/events